Forecasting

Post Holdings Reports Results for the Second Quarter of Fiscal Year 2024; Raises Fiscal Year 2024 Outlook

Retrieved on: 
Thursday, May 2, 2024
Post, GAAP, Cheese, Investment, Nature, Safety, Pet food, Forecasting, Public expenditure, RTE, Senior, Foodservice, Share repurchase, Adjustment, Accounting, Interest, Pharmaceutical industry

For the second quarter, net sales were $1,065.5 million, an increase of 77.9%, or $466.4 million, compared to the prior year period.

Key Points: 
  • For the second quarter, net sales were $1,065.5 million, an increase of 77.9%, or $466.4 million, compared to the prior year period.
  • For the second quarter, net sales were $138.0 million, an increase of 10.5%, or $13.1 million, compared to the prior year period.
  • For fiscal year 2024, Post management has raised its guidance range for Adjusted EBITDA to $1,335-$1,375 million from $1,290-$1,340 million.
  • ET to discuss financial results for the second quarter of fiscal year 2024 and fiscal year 2024 outlook and to respond to questions.

WW International, Inc. Announces First Quarter 2024 Results

Retrieved on: 
Thursday, May 2, 2024
Sequence, Nature, Average cost, Depreciation, Hand, Publishing, Webcast, Strategic planning, Forecasting, Wind, Digital, Tax, Operating cost, Acquisition, GAAP, Reinsurance

End of Period Subscribers in Q1 2024 were down 0.4% versus the prior year period.

Key Points: 
  • End of Period Subscribers in Q1 2024 were down 0.4% versus the prior year period.
  • Interest Rate Hedges: The Company’s interest rate swaps in effect as of the end of the first quarter of fiscal 2024 terminated on March 31, 2024.
  • During the conference call, Sima Sistani, Chief Executive Officer, and Heather Stark, Chief Financial Officer, will discuss the first quarter of fiscal 2024 results and answer questions from the investment community.
  • In addition, the Company presents certain of its financial results on a constant currency basis in addition to GAAP results.

From Switzerland to the World: Vtrading Launches Global Multilingual Artificial Intelligence Quantitative Trading System

Retrieved on: 
Friday, April 26, 2024
Language, Ecosystem, Interconnection, AI, Forecasting, API, Intelligence, Risk management, Environment, DNA, Professional, Face, Data analysis, Retail

Zurich, Switzerland, April 26, 2024 (GLOBE NEWSWIRE) -- Recently, Vtrading, an artificial intelligence-driven quantitative trading service brand from Switzerland, announced the launch of its global multilingual artificial intelligence quantitative trading system.Vtrading, as a brand deeply influenced by this innovative spirit, is committed to building an international cryptocurrency quantitative trading ecosystem.

Key Points: 
  • Zurich, Switzerland, April 26, 2024 (GLOBE NEWSWIRE) -- Recently, Vtrading, an artificial intelligence-driven quantitative trading service brand from Switzerland, announced the launch of its global multilingual artificial intelligence quantitative trading system.Vtrading, as a brand deeply influenced by this innovative spirit, is committed to building an international cryptocurrency quantitative trading ecosystem.
  • Vtrading's ecosystem design integrates diverse trading strategies, community interaction, and asset management tools, aiming to meet the wide-ranging needs of global users.
  • Furthermore, the Vtrading platform supports multilingual interaction, breaking through traditional market constraints with its user-friendly interface, enabling truly international operations.
  • It provides global users with a powerful and flexible trading environment, enabling them to operate efficiently and confidently in global markets and enjoy the diversification benefits of quantitative trading.

Pensa Systems Again Named Shelf Monitoring Solution of the Year

Retrieved on: 
Thursday, April 25, 2024
AI, Hand, Forecasting, Growth, CPG

Pensa digitizes the physical shelf at retail, bringing store inventory online to automatically spot stockouts, items running low and other problems in shelf planning and execution, freeing up time once spent identifying shelf issues to resolve those issues.

Key Points: 
  • Pensa digitizes the physical shelf at retail, bringing store inventory online to automatically spot stockouts, items running low and other problems in shelf planning and execution, freeing up time once spent identifying shelf issues to resolve those issues.
  • Outputs are precise and timely item-level data to spot granular “in the moment” shelf inventory issues and highly accurate trend data to improve overall shelf performance.
  • “Pensa’s highly efficient cloud-based system delivers accuracy, timeliness of insights, ease of use and efficiency making them again our pick for ‘Shelf Monitoring Solution of the Year’.
  • Pensa’s insights position their application as the clear source of truth for what is happening on the retail shelf through computer vision and advanced AI.”

Kirby Corporation Announces 2024 First Quarter Results

Retrieved on: 
Thursday, April 25, 2024
Marine, Weather, Transport, PIN, Commercial, News, Depreciation, Business administration, Security (finance), OEM, Webcast, Mississippi River, Forecasting, Illinois River, History, KDS, KEX, Public expenditure, Form, Wind, Tax, Distribution, Comparable, Methodist University, Tulane University, Southern Methodist University, Kirby Corporation, Telephone, Human, GAAP, Growth, Overalls, Finance, Rice University, Video game

Consolidated revenues for the 2024 first quarter were $808.0 million compared with $750.4 million reported for the 2023 first quarter.

Key Points: 
  • Consolidated revenues for the 2024 first quarter were $808.0 million compared with $750.4 million reported for the 2023 first quarter.
  • Marine transportation revenues for the 2024 first quarter were $475.4 million compared with $412.5 million for the 2023 first quarter.
  • Operating income for the 2024 first quarter was $83.0 million compared with $43.0 million for the 2023 first quarter.
  • Operating income for the 2024 first quarter was $22.0 million compared with $22.8 million for the 2023 first quarter.

Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024

Retrieved on: 
Wednesday, April 24, 2024
Debt-to-GDP ratio, Element, Acceleration, Probability, Depreciation, Security (finance), Convertible, CGT, Forecasting, CDMO, Environment, Operating cost, Acquisition, Quarter, Name, Biotechnology, GAAP, Note, Video game

TUSTIN, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced financial results for the third quarter and nine months ended January 31, 2024.

Key Points: 
  • Highlights from the Quarter Ended January 31, 2024, and Other Events:
    "I would first like to address the reasons for our delayed 10-Q filing for the third quarter of fiscal 2024,” stated Nick Green, president and CEO of Avid Bioservices.
  • “I will now turn to the positive results for our third quarter and first nine months of fiscal 2024.
  • “During the third quarter we had stronger revenues and an increase in bookings as compared to Q2 2024.
  • More detailed financial information and analysis may be found in Avid Bioservices’ Quarterly Report on Form 10-Q, which was filed with the Securities and Exchange Commission today.

Mark Hutchinson Joins F&M Bank as Treasurer

Retrieved on: 
Wednesday, April 24, 2024
Western Illinois University, MBA, University, Certified Management Accountant, Treasury, Bank, CMA, Farmer, Forecasting

ARCHBOLD, Ohio, April 24, 2024 (GLOBE NEWSWIRE) -- F&M Bank (“F&M”), an Archbold, Ohio-based bank owned by Farmers & Merchants Bancorp, Inc. (Nasdaq: FMAO) announced that Mark Hutchinson has joined F&M as Treasurer.

Key Points: 
  • ARCHBOLD, Ohio, April 24, 2024 (GLOBE NEWSWIRE) -- F&M Bank (“F&M”), an Archbold, Ohio-based bank owned by Farmers & Merchants Bancorp, Inc. (Nasdaq: FMAO) announced that Mark Hutchinson has joined F&M as Treasurer.
  • In this new position, Hutchinson will oversee certain financial operations including budgeting, planning, investing and other financial matters for the Bank.
  • Hutchinson will report to the Company’s Chief Financial Officer.
  • Lars Eller, President and Chief Executive Officer said, “Mark has an extensive background in asset and liability management, interest rate risk, liquidity, funds transfer pricing, budgeting, and forecasting.

Clover Health Appoints Healthcare Technology Veteran Peter Kuipers as Chief Financial Officer

Retrieved on: 
Monday, April 22, 2024
Weather Underground (weather service), Financial management, CFO, Weather, Executive, Kuipers, Omnicell, General Electric Company, Quantcast, The Weather Company, Business, Forecasting, Information technology, Altera, IPO, Clover Health, Intel, OMCL, Ernst & Young, File, Growth, Yahoo!, Management

FRANKLIN, Tenn., April 22, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company, today announced the appointment of Peter Kuipers as Chief Financial Officer (“CFO”), effective as of the day after the filing of the Company’s Quarterly Report on Form 10-Q for the quarter-ended March 31, 2024.

Key Points: 
  • FRANKLIN, Tenn., April 22, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company, today announced the appointment of Peter Kuipers as Chief Financial Officer (“CFO”), effective as of the day after the filing of the Company’s Quarterly Report on Form 10-Q for the quarter-ended March 31, 2024.
  • With a wealth of experience and a proven track record in financial management, Mr. Kuipers will drive strategic financial initiatives around profitability, growth and potential new revenue streams.
  • "We are thrilled to welcome Peter to Clover as our new Chief Financial Officer," said Andrew Toy, Chief Executive Officer, Clover Health.
  • “I am honored to join Clover at such an exciting time in its journey,” said Peter Kuipers.

Fobi AI Signs Data License Agreement with Vancouver Island Brewing to Deliver Enhanced Data Analytics & Insights

Retrieved on: 
Monday, April 22, 2024
Organization, VIB, Wine, AI, Beer, Data exchange, Traction, Partnership, Forecasting, Automation, RTD, Growth

VANCOUVER, BC, April 22, 2024 (GLOBE NEWSWIRE) --  Fobi AI Inc. (FOBI:TSXV) (FOBIF:OTCQB) (the "Company" or "Fobi"), an industry leader in harnessing AI and data intelligence to enable digital transformation, is pleased to announce that the Company has signed a data license agreement with Vancouver Island Brewing (VI Brewing), one of Canada’s original craft breweries. This strategic partnership will equip the brewery with advanced data analytics capabilities to drive exponential growth and innovation in today’s heavily competitive craft beer industry.

Key Points: 
  • Rob Anson, CEO of Fobi AI, states: “We are thrilled about the continuous growth and expansion of our partnership with Vancouver Island Brewing.
  • Additionally, we are proud of the recognition and validation that our Fobi Data Exchange brings to the beverage and liquor industry.
  • With 40 years of brewing excellence, Vancouver Island Brewing consistently strives to remain at the forefront of trends, innovation, and technological advancements.
  • To download the Fobi Investor Experience Wallet Pass to get enhanced access to investor information about Fobi, please visit our Investor Experience page .

Alterity Therapeutics Parkinson’s Disease and Multiple System Atrophy Data Featured at the American Academy of Neurology (AAN) 2024 Annual Meeting

Retrieved on: 
Wednesday, April 17, 2024
Molecule, Neuroimaging, American Academy, Brain, Iron, Oxidative stress, MSA, AFL, Poster, Disease, Vanderbilt University, Substantia nigra, Plasma, ASX, Pathology, Neurofilament, Forecasting, Macaque, Nerve, Multiple system atrophy, Patient, Treatment, Observational study, AAN, CSF, Neuron, Biomarker, Annual general meeting, Vanderbilt University Medical Center, Therapy, Cerebrospinal fluid, Parkinsonism, ATH, Frasier, SAN, Medical imaging

MELBOURNE, Australia and SAN FRANCISCO, April 17, 2024 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that three posters were presented at the American Academy of Neurology (AAN) 2024 Annual Meeting taking place April 13-18, 2024, in Denver, Colorado, USA. Featured presentations described the Company’s work in Parkinson’s disease and Multiple System Atrophy (MSA), including initial biomarker data and baseline characteristics from the ATH434-201 Phase 2 clinical trial.

Key Points: 
  • Featured presentations described the Company’s work in Parkinson’s disease and Multiple System Atrophy (MSA), including initial biomarker data and baseline characteristics from the ATH434-201 Phase 2 clinical trial.
  • At AAN we reported the baseline characteristics from our ATH434-201 Phase 2 trial including fluid biomarkers and neuroimaging data.
  • The data showed increased iron in areas of pathology and elevated plasma Neurofilament Light Chain (NfL) levels at baseline that correlated significantly with disease severity.
  • Plasma NfL significantly increased over 12 months, and both plasma and CSF NfL were associated with disease progression in MSA.